(Q37141172)

18 August 2017

1 reference

title

Strategies for herpes zoster vaccination of immunocompromised patients (English)

1 reference

18 August 2017

1 reference

Jeffrey I Cohen

1

1 reference

PMC publication ID

2679676

18 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

Journal of Infectious Diseases

18 August 2017

1 reference

18 August 2017

197 Suppl 2

1 reference

18 August 2017

S237-41

1 reference

A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Use of varicella vaccines to prevent herpes zoster in older individuals

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Characterization of Varicella-Zoster virus glycoprotein K (open reading frame 5) and its role in virus growth

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Postherpetic neuralgia--pathogenesis, treatment, and prevention

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP)

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2679676

Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older

20 October 2018

1 reference

12 December 2020

Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells

1 reference

12 December 2020

Immunization of HIV-infected children with varicella vaccine

1 reference

12 December 2020

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants

1 reference

12 December 2020

Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine

1 reference

12 December 2020

Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine

1 reference

12 December 2020

Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults

1 reference

12 December 2020

Safety, tolerability, and immunogenicity of two regimens of Oka/Merck varicella vaccine (Varivax) in healthy adolescents and adults. Oka/Merck Varicella Vaccine Study Group

1 reference

12 December 2020

Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention

1 reference

12 December 2020

Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada

1 reference

12 December 2020

Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine

1 reference

12 December 2020

Identifiers

DOI

10.1086/522129

1 reference

18 August 2017

1 reference

PMC publication ID

2679676

18 August 2017

PubMed publication ID

18419403

1 reference

PMC publication ID

2679676